BAT8010 for Injection: Clinical Trials

2 trials of BAT8010 for Injection, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 active not recruiting, 1 completed. 2 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 12Active not recruiting 1, Completed 1
Phase 21Active not recruiting 1

Follow BAT8010 for Injection: new trials by email Literature Review of BAT8010 for Injection trials Research Report on BAT8010 for Injection

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Multicenter Open Clinical Study of Safety, Tolerability, Pharmacokinetic Profile, and Initial Clinical Efficacy of BAT 8010 for Injection Combined With BAT 1006 in the Treatment of Locally Advanced or Metastatic Tumors
BAT8010 for Injection, BAT1006 for Injection - Advanced Solid Tumors
Phase 1 / Phase 2Active not recruitingBio-Thera Solutions2182024-05-082026-09-30
Assessment of Safety, Tolerability and Pharmacokinetics With BAT8010 for Injection in Advanced Malignant Solid Tumors Patients
BAT8010 for Injection - Advanced or Metastatic Solid Tumors
Phase 1CompletedBio-Thera Solutions232023-02-102026-03-30

Sponsors

Bio-Thera Solutions (2)

Countries

China (2)

Top investigators

Chaohe Wang (1)  ·  Ruihua Xu (1)